An FDA official said the agency needs funding in addition to outsourcing facility fees to carry out the new drug compounding authorities provided by the recently enacted Drug Quality and Security Act, especially since enforcement will not be solely focused on facilities registered under the new law. Sally Howard, FDA's deputy commissioner for policy, planning and legislation, told FDA funding advocates Tuesday (Feb. 4) that the agency is concerned the law does not provide adequate funding for the agency to enforce its new authorities
continue to read here
continue to read here
No comments:
Post a Comment